References
- RicardDIdbaihADucrayFLahutteMHoang-XuanKDelattreJYPrimary brain tumours in adultsLancet201237998301984199622510398
- WestphalMLamszusKThe neurobiology of gliomas: from cell biology to the development of therapeutic approachesNat Rev Neurosci201112949550821811295
- SchwartzbaumJAFisherJLAldapeKDWrenschMEpidemiology and molecular pathology of gliomaNat Clin Pract Neurol200629494503 quiz 1 p following 51616932614
- LapointeSPerryAButowskiNAPrimary brain tumours in adultsLancet20183921014543244630060998
- DiamandisPAldapeKDInsights from molecular profiling of adult gliomaJ Clin Oncol201735212386239328640696
- ChenJMcKayRMParadaLFMalignant glioma: lessons from genomics, mouse models, and stem cellsCell20121491364722464322
- MillerGBrain cancer. A viral link to glioblastoma?Science20093235910303119119195
- LussoPHuman herpesvirus 6 (HHV-6)Antiviral Res1996311–21218793005
- RantalaHMannonenLAhtiluotoSHuman herpesvirus-6 associated encephalitis with subsequent infantile spasms and cerebellar astrocytomaDev Med Child Neurol200042641842110875530
- CohenJIHuman herpesvirus types 6 and 7 (exanthema subitum)BennettJEDolinRBlaserMJMandell, Douglas, and Bennett’s Principles and Practice of Infectious Diseases8th ed2PhiladelphiaElsevier Saunders201517721776
- FotheringhamJDonatiDAkhyaniNAssociation of human herpesvirus-6B with mesial temporal lobe epilepsyPLoS Med200745e18017535102
- ChiJGuBZhangCHuman herpesvirus 6 latent infection in patients with gliomaJ Infect Dis201220691394139822962688
- CrawfordJRSantiMRCornelisonRSallinenSLHaapasaloHMac-DonaldTJDetection of human herpesvirus-6 in adult central nervous system tumors: predominance of early and late viral antigens in glial tumorsJ Neurooncol2009951496019424665
- CrawfordJRSantiMRThorarinsdottirHKDetection of human herpesvirus-6 variants in pediatric brain tumors: association of viral antigen in low grade gliomasJ Clin Virol2009461374219505845
- AblashiDAgutHAlvarez-LafuenteRClassification of HHV-6A and HHV-6B as distinct virusesArch Virol2014159586387024193951
- ThomsonBJWeindlerFWGrayDSchwaabVHeilbronnRHuman herpesvirus 6 (HHV-6) is a helper virus for adeno-associated virus type 2 (AAV-2) and the AAV-2 rep gene homologue in HHV-6 can mediate AAV-2 DNA replication and regulate gene expressionVirology199420413043118091661
- LindenRMWardPGiraudCWinocourEBernsKISite-specific integration by adeno-associated virusProc Natl Acad Sci U S A1996932111288112948876128
- AraujoJCDonigerJStöpplerHSadaieMRRosenthalLJCell lines containing and expressing the human herpesvirus 6A ts gene are protected from both H-ras and BPV-1 transformationOncogene19971489379439050993
- CaselliEBracciAGalvanMHuman herpesvirus 6 (HHV-6) U94/REP protein inhibits betaherpesvirus replicationVirology2006346240241416368124
- CarusoACaselliEFiorentiniSU94 of human herpesvirus 6 inhibits in vitro angiogenesis and lymphangiogenesisProc Natl Acad Sci U S A200910648204462045119918067
- IfonETPangALJohnsonWU94 alters FN1 and ANGPTL4 gene expression and inhibits tumorigenesis of prostate cancer cell line PC3Cancer Cell Int200551915972109
- CarmelietPJainRKMolecular mechanisms and clinical applications of angiogenesisNature2011473734729830721593862
- Ala-ahoRKähäriVMCollagenases in cancerBiochimie2005873–427328615781314
- WangSMaGZhuHmiR-107 regulates tumor progression by targeting NF1 in gastric cancerSci Rep201663653127827403
- GuBZhangGFLiLYHuman herpesvirus 6A induces apoptosis of primary human fetal astrocytes via both caspase-dependent and -independent pathwaysVirol J2011853022152093
- RotolaARavaioliTGonelliADewhurstSCassaiEDi LucaDU94 of human herpesvirus 6 is expressed in latently infected peripheral blood mononuclear cells and blocks viral gene expression in transformed lymphocytes in cultureProc Natl Acad Sci U S A1998952313911139169811900
- GuBZhangGLiLZhouFFengDYaoKHuman herpesvirus 6A subtype latent infection of human glioma cell line U251Acta Univ Med Nanjing20151013391343 Chinese
- AlbiniATosettiFLiVWNoonanDMLiWWCancer prevention by targeting angiogenesisNat Rev Clin Oncol20129949850922850752
- CrossMJClaesson-WelshLFGF and VEGF function in angiogenesis: signalling pathways, biological responses and therapeutic inhibitionTrends Pharmacol Sci200122420120711282421
- HenkemeyerMRossiDJHolmyardDPVascular system defects and neuronal apoptosis in mice lacking ras GTPase-activating proteinNature199537765516957017477259
- KlintPKandaSKloogYClaesson-WelshLContribution of Src and Ras pathways in FGF-2 induced endothelial cell differentiationOncogene199918223354336410362356
- HeHVenemaVJGuXVenemaRCMarreroMBCaldwellRBVascular endothelial growth factor signals endothelial cell production of nitric oxide and prostacyclin through flk-1/KDR activation of c-SrcJ Biol Chem199927435251302513510455194
- CrossMJHodgkinMNRobertsSLandgrenEWakelamMJClaesson-WelshLTyrosine 766 in the fibroblast growth factor receptor-1 is required for FGF-stimulation of phospholipase C, phospholipase D, phospholipase A(2), phosphoinositide 3-kinase and cytoskeletal reorganisation in porcine aortic endothelial cellsJ Cell Sci2000113Pt 464365110652257
- GerberHPMcMurtreyAKowalskiJVascular endothelial growth factor regulates endothelial cell survival through the phosphatidylinosi-tol 3’-kinase/Akt signal transduction pathway. Requirement for Flk-1/KDR activationJ Biol Chem19982734630336303439804796
- TakahashiTShibuyaMThe 230 kDa mature form of KDR/Flk-1 (VEGF receptor-2) activates the PLC-gamma pathway and partially induces mitotic signals in NIH3T3 fibroblastsOncogene19971417207920899160888
- DempkeWCHeinemannVResistance to EGF-R (erbB-1) and VEGF-R modulating agentsEur J Cancer20094571117112819124237
- HuXPaikPKChenJIFN-gamma suppresses IL-10 production and synergizes with TLR2 by regulating GSK3 and CREB/AP-1 proteinsImmunity200624556357416713974
- DufourASampsonNSZuckerSCaoJRole of the hemopexin domain of matrix metalloproteinases in cell migrationJ Cell Physiol2008217364365118636552
- Redondo-MuñozJUgarte-BerzalETerolMJMatrix metal-loproteinase-9 promotes chronic lymphocytic leukemia b cell survival through its hemopexin domainCancer Cell201017216017220159608
- WheelerDLDunnEFHarariPMUnderstanding resistance to EGFR inhibitors-impact on future treatment strategiesNat Rev Clin Oncol20107949350720551942
- ChettyCLakkaSSBhoopathiPRaoJSMMP-2 alters VEGF expression via alphaVbeta3 integrin-mediated PI3K/AKT signaling in A549 lung cancer cellsInt J Cancer201012751081109520027628
- YoshikawaTAsanoYAkimotoSLatent infection of human her-pesvirus 6 in astrocytoma cell line and alteration of cytokine synthesisJ Med Virol200266449750511857528
- MoriYDhepaksonPShimamotoTExpression of human herpesvirus 6B rep within infected cells and binding of its gene product to the TATA-binding protein in vitro and in vivoJ Virol200074136096610410846093
- KashanchiFAraujoJDonigerJHuman herpesvirus 6 (HHV-6) ORF-1 transactivating gene exhibits malignant transforming activity and its protein binds to p53Oncogene19971433593679018122
- LacroixACollot-TeixeiraSMardivirinLInvolvement of human herpesvirus-6 variant B in classic Hodgkin’s lymphoma via DR7 oncoproteinClin Cancer Res201016194711472120858841